Literature DB >> 19383789

Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Stina Friling1, Elisabet Andersson, Lachlan H Thompson, Marie E Jönsson, Josephine B Hebsgaard, Evanthia Nanou, Zhanna Alekseenko, Ulrika Marklund, Susanna Kjellander, Nikolaos Volakakis, Outi Hovatta, Abdeljabbar El Manira, Anders Björklund, Thomas Perlmann, Johan Ericson.   

Abstract

Signaling factors involved in CNS development have been used to control the differentiation of embryonic stem cells (ESCs) into mesencephalic dopamine (mesDA) neurons, but tend to generate a limited yield of desired cell type. Here we show that forced expression of Lmx1a, a transcription factor functioning as a determinant of mesDA neurons during embryogenesis, effectively can promote the generation of mesDA neurons from mouse and human ESCs. Under permissive culture conditions, 75%-95% of mouse ESC-derived neurons express molecular and physiological properties characteristic of bona fide mesDA neurons. Similar to primary mesDA neurons, these cells integrate and innervate the striatum of 6-hydroxy dopamine lesioned neonatal rats. Thus, the enriched generation of functional mesDA neurons by forced expression of Lmx1a may be of future importance in cell replacement therapy of Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383789      PMCID: PMC2671325          DOI: 10.1073/pnas.0902396106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

Review 1.  Specification of dopaminergic and serotonergic neurons in the vertebrate CNS.

Authors:  M Hynes; A Rosenthal
Journal:  Curr Opin Neurobiol       Date:  1999-02       Impact factor: 6.627

2.  Identification of intrinsic determinants of midbrain dopamine neurons.

Authors:  Elisabet Andersson; Ulrika Tryggvason; Qiaolin Deng; Stina Friling; Zhanna Alekseenko; Benoit Robert; Thomas Perlmann; Johan Ericson
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

Review 3.  Cell therapy in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  NeuroRx       Date:  2004-10

4.  Early neuromeric distribution of tyrosine-hydroxylase-immunoreactive neurons in human embryos.

Authors:  L Puelles; C Verney
Journal:  J Comp Neurol       Date:  1998-05-11       Impact factor: 3.215

5.  An evolutionarily conserved region in the second intron of the human nestin gene directs gene expression to CNS progenitor cells and to early neural crest cells.

Authors:  C Lothian; U Lendahl
Journal:  Eur J Neurosci       Date:  1997-03       Impact factor: 3.386

6.  High-purity lineage selection of embryonic stem cell-derived neurons.

Authors:  Tanja Schmandt; Eybe Meents; Gudrun Gossrau; Volker Gornik; Shigeo Okabe; Oliver Brüstle
Journal:  Stem Cells Dev       Date:  2005-02       Impact factor: 3.272

7.  Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections.

Authors:  Lachlan Thompson; Perrine Barraud; Elin Andersson; Deniz Kirik; Anders Björklund
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

8.  Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts.

Authors:  Andreas Toft Sørensen; Lachlan Thompson; Deniz Kirik; Anders Björklund; Olle Lindvall; Merab Kokaia
Journal:  Eur J Neurosci       Date:  2005-05       Impact factor: 3.386

9.  Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

Authors:  Ivar Mendez; Rosario Sanchez-Pernaute; Oliver Cooper; Angel Viñuela; Daniela Ferrari; Lars Björklund; Alain Dagher; Ole Isacson
Journal:  Brain       Date:  2005-05-04       Impact factor: 13.501

10.  Dopamine neuron agenesis in Nurr1-deficient mice.

Authors:  R H Zetterström; L Solomin; L Jansson; B J Hoffer; L Olson; T Perlmann
Journal:  Science       Date:  1997-04-11       Impact factor: 47.728

View more
  70 in total

1.  Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain.

Authors:  Vladimer Darsalia; Susan J Allison; Carlo Cusulin; Emanuela Monni; Daniela Kuzdas; Therése Kallur; Olle Lindvall; Zaal Kokaia
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-09       Impact factor: 6.200

Review 2.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 3.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

4.  Dopaminergic neurons for Parkinson's therapy.

Authors:  Olle Lindvall
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

5.  Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.

Authors:  Emmanouil Metzakopian; Wei Lin; Mali Salmon-Divon; Heidi Dvinge; Elisabet Andersson; Johan Ericson; Thomas Perlmann; Jeffrey A Whitsett; Paul Bertone; Siew-Lan Ang
Journal:  Development       Date:  2012-06-13       Impact factor: 6.868

6.  Tracking differentiating neural progenitors in pluripotent cultures using microRNA-regulated lentiviral vectors.

Authors:  Rohit Sachdeva; Marie E Jönsson; Jenny Nelander; Agnete Kirkeby; Carolina Guibentif; Bernhard Gentner; Luigi Naldini; Anders Björklund; Malin Parmar; Johan Jakobsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

7.  What can pluripotent stem cells teach us about neurodegenerative diseases?

Authors:  Hynek Wichterle; Serge Przedborski
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

Review 8.  Direct somatic lineage conversion.

Authors:  Koji Tanabe; Daniel Haag; Marius Wernig
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 9.  Understanding Parkinson's Disease through the Use of Cell Reprogramming.

Authors:  Rebecca Playne; Bronwen Connor
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

10.  Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.

Authors:  Ariadna Laguna; Nicoletta Schintu; André Nobre; Alexandra Alvarsson; Nikolaos Volakakis; Jesper Kjaer Jacobsen; Marta Gómez-Galán; Elena Sopova; Eliza Joodmardi; Takashi Yoshitake; Qiaolin Deng; Jan Kehr; Johan Ericson; Per Svenningsson; Oleg Shupliakov; Thomas Perlmann
Journal:  Nat Neurosci       Date:  2015-04-27       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.